D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −107,432−100.0% | Sold out | Holders |
| Q1 2025 | 107,432 | $568.3K | <0.1% | +91,440+571.8% | Added | Holders |
| Q4 2024 | 15,992 | $108.1K | <0.1% | −98,047−86.0% | Reduced | Holders |
| Q3 2024 | 114,039 | $751.5K | <0.1% | +6,505+6.0% | Added | Holders |
| Q2 2024 | 107,534 | $806.5K | <0.1% | +96,895+910.8% | Added | Holders |
| Q1 2024 | 10,639 | $106.1K | <0.1% | +10,639 | New | Holders |